Composition
- Active ingredients
- TELISOTUZUMAB VEDOTIN-TLLV 100MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TELISOTUZUMAB VEDOTIN-TLLV 20MG · VialBLA761384-001 · Prescription
- TELISOTUZUMAB VEDOTIN-TLLV 100MG · VialThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761384.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Emrelis
- Active substance
- telisotuzumab vedotin-tllv
- Route
- Single-dose
- Dosage form
- Vial
- Applicant
- Abbvie Inc
- Status
- Prescription
- FDA approval
- 14 May 2025
- Application
- BLA761384-002